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ABSTRACT The extended-spectrum--lactamase (ESBL)- and Klebsiella pneumoniae
carbapenemase (KPC)-producing Enterobacteriaceae represent serious and urgent
threats to public health. In a retrospective study of multidrug-resistant K. pneu-
moniae, we identiﬁed three clinical isolates, CN1, CR14, and NY9, carrying both
blaCTX-M and blaKPC genes. The complete genomes of these three K. pneumoniae iso-
lates were de novo assembled by using both short- and long-read whole-genome se-
quencing. In CR14 and NY9, blaCTX-M and blaKPC were carried on two different plas-
mids. In contrast, CN1 had one copy of blaKPC-2 and three copies of blaCTX-M-15
integrated in the chromosome, for which the blaCTX-M-15 genes were linked to an in-
sertion sequence, ISEcp1, whereas the blaKPC-2 gene was in the context of a Tn4401a
transposition unit conjugated with a PsP3-like prophage. Intriguingly, downstream of
the Tn4401a-blaKPC-2-prophage genomic island, CN1 also carried a clustered regularly
interspaced short palindromic repeat (CRISPR)-cas array with four spacers targeting a
variety of K. pneumoniae plasmids harboring antimicrobial resistance genes. Compar-
ative genomic analysis revealed that there were two subtypes of type I-E CRISPR-cas
in K. pneumoniae strains and suggested that the evolving CRISPR-cas, with its ac-
quired novel spacer, induced the mobilization of antimicrobial resistance genes from
plasmids into the chromosome. The integration and dissemination of multiple copies
of blaCTX-M and blaKPC from plasmids to chromosome depicts the complex pandemic
scenario of multidrug-resistant K. pneumoniae. Additionally, the implications from
this study also raise concerns for the application of a CRISPR-cas strategy against an-
timicrobial resistance.
KEYWORDS CRISPR-Cas, CTX-M, carbapenem-resistance, chromosomal beta-
lactamases, Klebsiella pneumoniae, blaKPC
The acquisition and spread of -lactamases among bacterial species has led toincreased resistance to -lactam antibiotics. Such resistance constitutes an urgent
threat to patient management and public health (1). In the mid-1980s, extended-
spectrum -lactamases (ESBLs) were ﬁrst detected. To date, the Centers for Disease
Control and Prevention (CDC) estimate that ESBL-producing Enterobacteriaceae cause
at least 26,000 health care-associated infections and 1,700 deaths per year in the United
States (1). Among the many types of ESBLs reported (2, 3), CTX-M enzymes are the most
prevalent (3). Although the dominant variants of CTX-M are geographically different,
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CTX-M-15 and CTX-M-14 are the most common ones identiﬁed worldwide (3). More-
over, the genes encoding CTX-M enzymes (blaCTX-M) can be horizontally mobilized by
various genetic elements. An insertion sequence (IS), ISEcp1, is often associated with the
region upstream of blaCTX-M genes and provides promoters to regulate blaCTX-M ex-
pression (3).
Carbapenem-resistant Enterobacteriaceae (CRE) have also emerged and rapidly
spread worldwide. Each year, approximately 600 deaths result from CRE infections in
the United States (1). Carbapenemases are a diverse group of -lactamases that are
active against oxyimino-cephalosporins and cephamycins as well as carbapenems.
Among these, Klebsiella pneumoniae carbapenemase (KPC) is currently the most prev-
alent (4), with KPC-2 and KPC-3 being the most common variants in the United States
(5). Genetically, the gene encoding KPC (blaKPC) has been identiﬁed within a 10-kb
Tn3-family transposon, Tn4401 (6). The mobile genetic element Tn4401 possesses a
transposase gene (tnpA) and a resolvase gene (tnpR), in addition to two unrelated ISs,
ISKpn6 and ISKpn7.
Klebsiella pneumoniae is an opportunistic pathogen causing severe infections in
patients, especially neonates, the elderly, and immunocompromised individuals (7).
Emergence and facilitated spread of multidrug-resistant (MDR) K. pneumoniae, such as
the ESBL (8–10)- and KPC-producing strains (4, 5, 11), are often responsible for the
failure of antibiotic treatment (1). K. pneumoniae isolates carrying both blaCTX-M and
blaKPC were ﬁrst reported in New York City in 2013 (12). However, the genetic structure
of these coexisting -lactamases and mechanism of transmission are unclear. Limited
data suggest that blaKPC and blaCTX-M are most commonly carried by promiscuous
plasmids that readily transfer among Enterobacteriaceae species (13–16). K. pneumoniae
strains containing multiple copies of -lactamase genes in the chromosome, especially
the same -lactamase gene, are rare.
We previously examined K. pneumoniae clinical isolates collected between 2005 and
2012 at the Westchester Medical Center (WMC), New York, for the presence of ESBL and
KPC -lactamase genes, including blaTEM, blaSHV, blaCTX-M, and blaKPC, by PCR and DNA
sequencing (17). In a subsequent study using next-generation sequencing, we analyzed
additional K. pneumoniae isolates collected at the WMC between 2012 and 2014 and at
two New York City hospitals collected in 2013. We obtained the complete genome
sequences of three K. pneumoniae clinical isolates harboring both blaCTX-M and blaKPC.
In this report, we present the comparative genomic analysis data that reveal the
emergence and potential evolution of K. pneumoniae strains carrying multiple chro-
mosomal -lactamase genes. We also investigated the molecular mechanism poten-
tially associated with such chromosomal integration of antibiotic resistance genes.
(Part of this study was presented in a poster at the Association of Molecular
Pathology 2016 Annual Meeting, Charlotte, NC, 10 to 12 November 2016.)
RESULTS
Whole-genome sequences of K. pneumoniae CN1, NY9, and CR14. Three K.
pneumoniae isolates, CN1, NY9, and CR14, were conﬁrmed to carry both blaCTX-M and
blaKPC genes. CN1 and NY9 were recovered from two patients in New York City in 2013,
whereas CR14 was cultured from a WMC patient in 2012. To obtain complete genome
sequence for structural analysis, we employed both short- and long-read sequencing
and conducted de novo assembly. The genomic characteristics based on ﬁnal complete
genome sequences of these three isolates are summarized in Table 1. Brieﬂy, K.
pneumoniae isolates CN1, NY9, and CR14 belong to ST392, ST340, and ST258, with
corresponding genome sizes of 5.44, 5.88, and 6.06 Mb, respectively. Each strain
contains a circular chromosome, with a GC content of about 57.5%, similar to those of
other K. pneumoniae strains publicly available. A comparison of their chromosomal
architectures is shown in Fig. 1A. Compared to CN1 and NY9, CR14 had a relatively
larger genome, with a large insertion (171-kb) and a large inversion (245-kb) in the
chromosome. While CR14 and NY9 contained ﬁve and six circular plasmids, respec-
tively, CN1 had only two circular plasmids.
Huang et al. Antimicrobial Agents and Chemotherapy
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From the whole-genome sequences, we identiﬁed multiple antimicrobial resistance
genes, in either chromosomes or plasmids (see Table S1 in the supplemental material).
Among these, multiple -lactamase genes were identiﬁed in each of the three K.
pneumoniae isolates: CR14 carried blaCTX-M-2, blaOXA-2, and blaTEM-1B in plasmid
pCR14_2 (154 kb) with an A/C2 replicon, as well as blaKPC-2, blaOXA-9, and blaTEM-1A in
another plasmid, pCR14_3 (116 kb), with two replicons, FIB and FIIK. Isolate NY9 carried
blaSHV-11 in the chromosome; blaKPC-3, blaOXA-9, and blaTEM-1A in plasmid pNY9_2 (140
kb) with two replicons, FIA and FII; and blaCTX-M-15, blaOXA-1, and blaTEM-1B in another
plasmid, pNY9_3 (89 kb), with an FII replicon. Interestingly, both blaKPC-carrying plas-
mids contained two replicons, whereas both blaCTX-M-carrying plasmids only had one.
More remarkably, CN1 carried three copies of blaCTX-M-15, in addition to one copy of
blaSHV-11 and blaKPC-2, in the chromosome (Fig. 1A), with only blaOXA-1 in plasmid
pCN1_1 (183 kb).
Chromosomal blaCTX-M-15 and blaKPC-2 in K. pneumoniae. The coexistence of
chromosomal blaCTX-M-15 and blaKPC-2 is rare and raised our interest. In search of
homologous genome sequence similar to that of the CN1 chromosome, we identiﬁed
K. pneumoniae isolate KPNIH31, which was recovered from a patient in the United
States in 2013 (15). Both CN1 and KPNIH31 belonged to ST392, with the same GC
content of 57.5%. These two isolates shared a small, 15.1-kb plasmid (pCN1_2 or
pAAC154-a9e). Their largest plasmid (pCN1_1, 183 kb; and pKPN-c22, 179 kb) and
chromosome (CN1, 5.24 Mb; and KPNIH31, 5.23 Mb) also had similar sizes (Table S3) and
showed high nucleotide sequence identity of more than 99% over the coverage of
more than 98% of chromosomal and plasmid sequences. However, KPNIH31 carried an
extra plasmid, pKPN-852, in which no antimicrobial resistance gene was found. Genome
sequence alignment demonstrated that compared to CN1, KPNIH31 had a 60-kb
TABLE 1 Genomic characteristics of K. pneumoniae clinical isolates CR14, NY9, and CN1
with both blaCTX-M and blaKPC genes
Genomic characteristica
Finding for strain:
CR14 NY9 CN1
MLST ST258 ST340 ST392
Chromosome size (Mb) 5.47 5.35 5.24
GC (%) 57.3 57.5 57.5
No. of coding genes 5,884 5,776 5,224
RNAs (no.)
rRNA 25 25 25
tRNA 85 88 87
Plasmids
No. of plasmids 5 6 2
Plasmid (size) pCR14_1 (203 kb) pNY9_1 (199 kb) pCN1_1 (183 kb)
pCR14_2 (154 kb) pNY9_2 (140 kb) pCN1_2 (15 kb)
pCR14_3 (116 kb) pNY9_3 (89 kb)
pCR14_4 (110 kb) pNY9_4 (53 kb)
pCR14_5 (9 kb) pNY9_5 (39 kb)
pNY9_6 (11 kb)
ESBL and KPC -lactamases
blaCTX-M
Allele (no. of copies) blaCTX-M-2 (1) blaCTX-M-15 (1) blaCTX-M-15 (3)
Genetic location pCR14_2 pNY9_3 Chromosome
blaKPC
Allele (no. of copies) blaKPC-2 (1) blaKPC-3 (1) blaKPC-2 (1)
Genetic location pCR14_3 pNY9_2 Chromosome
CRISPR on chromosome No No Yes
aRefer to supplemental materials for a complete list of antimicrobial resistance genes, including other non-
ESBL and KPC -lactamases (Table S1) and antimicrobial susceptibility proﬁles (Table S2) of these three
clinical isolates. MLST, multilocus sequence typing; CRISPR: clustered regularly interspaced short palindromic
repeats.
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inversion in the chromosome (Fig. 1B). Interestingly, KPNIH31 also harbored both
blaCTX-M-15 and blaKPC-2 in the chromosome.
Insertions of three copies of blaCTX-M-15 in the CN1 chromosome were found to be
associated with the same mobile element, ISEcp1, despite their different insertion sizes
(Fig. 2A and B). This feature was consistent with transposition events of blaCTX-M-15 in
plasmids, as seen in plasmid pNY9_3 of isolate NY9. In the context of these blaCTX-M-15
genes, we identiﬁed a 5-bp target site duplication (TSD) sequence for each ISEcp1 copy
(Fig. 2B). Interestingly, the second ISEcp1-blaCTX-M-15 copy in isolate CN1 was not
complete, with the left TSD eliminated and the ISEcp1 transposase truncated at the 5=
end (Fig. 2B), suggesting a sequence deletion occurred after ISEcp1-blaCTX-M-15 inser-
tion. Unlike isolate CN1, KPNIH31 had only one complete copy of the ISEcp1-blaCTX-M-15
unit. While the third ISEcp1-blaCTX-M-15 unit was totally eliminated in KPNIH31, the
second ISEcp1-blaCTX-M-15 unit was also truncated and further interrupted by an inser-
tion of IS903 in the middle of blaCTX-M-15, followed by an inversion (Fig. 2C).
In addition to the three insertions of ISEcp1-blaCTX-M-15, the CN1 chromosome
retained an insertion of Tn4401a-blaKPC-2 in a genomic island (Fig. 3A). There were only
FIG 1 Overview of whole-chromosome sequence comparisons using progressive Mauve. (A) Chromosome comparison of K. pneumoniae isolates CR14, NY9, and
CN1. Indicated are locations of -lactamase genes (blaCTX-M-15 and blaKPC-2), prophages (), and the CRISPR site, as well as a large inversion in the CR14
chromosome. The boxed areas and CRISPR site are shown in more detail in later ﬁgures. (B) Chromosome comparison of K. pneumoniae isolates MS6671, CN1,
and KPNIH31. Indicated are multiple -lactamase genes, blaCTX-M-15, blaKPC-2, and blaOXA-181, and a large inversion in the KPNIH31 chromosome. A homologous
PsP3-like prophage () and a similar CRISPR-cas array (labeled in red font) are shared by these chromosomes. For a better view of sequence alignment and
chromosomal architecture in comparison, genome sequences of KPNIH31 (2013, United States) and MS6671 (2014, United Arab Emirates) are adjusted to dnaA
as the ﬁrst gene.
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two additional Enterobacteriaceae strains, the aforementioned K. pneumoniae KPNIH31
(15) and Proteus mirabilis AOUC-001, isolated from Italy in 2013 (18), which carry the
chromosomal blaKPC-2 gene. The blaKPC-2 gene in these chromosomes shared the same
mobile genetic element as the plasmids, a 10-kb Tn4401a ﬂanked by two 38-bp
imperfect but conserved inverted repeats (IRL and IRR) (Fig. 3B). However, we observed
FIG 2 Integration of blaCTX-M-15 in the chromosome by mobile element ISEcp1. (A) A zoomed-in view of
three blaCTX-M-15 genes inserted in the CN1 chromosome, compared with chromosomes of CR14 and NY9.
The blue arrow indicates a mobile element of ISEcp1-blaCTX-M-15. (B) A schematic view of genetic elements
in 3-kb mobile elements of ISEcp1-blaCTX-M-15 in the CN1 chromosome. IRL, left inverted repeat; IRR, right
inverted repeat; tnpA, gene encoding transposase A type; trpB-like, gene encoding tryptophan synthase
subunit beta-like protein. The target site duplication (TSD) sequences are shown at the ends. The
suggested deletion was marked on the second copy of ISEcp1-blaCTX-M-15. (C) A schematic view of the second
copies of ISEcp1-blaCTX-M-15 in CN1 and KPNIH31 chromosomes. The second copy of ISEcp1-blaCTX-M-15 in
KPNIH31 was disrupted by IS903 insertion. Indicated with a red arrow is the interruption site. Insertion of IS903
interrupts the blaCTX-M-15 gene in the middle and further inverts a truncated part of ISEcp1 (shaded gray). IRR,
right inverted repeat.
Chromosomal blaKPC and blaCTX-M in K. pneumoniae Antimicrobial Agents and Chemotherapy
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that the paired 5-bp TSD sequences of transposon Tn4401a-blaKPC-2 in chromosomes
did not match perfectly those in plasmids, such as in pCR14_3 of isolate CR14 (Fig. 3C).
This feature of chromosomal Tn4401a-blaKPC-2 differed from that of chromosomal
ISEcp1-blaCTX-M-15.
Both CN1 and KPNIH31 had an identical genomic island, with an aforementioned
10-kb Tn4401a-blaKPC-2 transposon conjugated to a 43-kb Enterobacteriaceae phage
PsP3-like prophage. The whole prophage region contained about 50 genes coding for
one tRNA and 49 proteins. Among these, 44 proteins (90%) had high similarity to phage
proteins, and 30 proteins (61%) were highly homologous to the proteins in bacterio-
phage PsP3, isolated from Salmonella. Sequence homology search further revealed that
this prophage region could also be found in the chromosomes of K. pneumoniae
FIG 3 Integration of blaKPC-2 in the chromosome by a mobile element, Tn4401a. (A) A zoomed-in view of
blaKPC-2 insertion in the CN1 chromosome by a 10-kb Tn4401a conjugated with a 43-kb PsP3-like
prophage and compared with chromosomes of CR14 and NY9. (B) A schematic view of genetic elements
in a 10-kb mobile element of Tn4401a-blaKPC-2, including transposase tnpA, resolvase tnpR, and insertion
sequences ISKpn6 and ISKpn7. IRL, left inverted repeat; IRR, right inverted repeat. (C) Comparison of target
site duplication (TSD) sequences of Tn4401a-blaKPC-2 transposon in plasmid pCR14_3 (p3) with those in
chromosomes of K. pneumoniae CN1 and KPNIH31 (2013, United States) and Proteus mirabilis AOUC-001
(2013, Italy). The numbers shown indicate nucleotide positions at either chromosome or plasmid. (D) A
schematic view of PsP3-like prophage region in K. pneumoniae MS6671, CN1, and KPNIH31. MS6671
contained both 32-bp phage attachment sites (attL and attR) at the ends, whereas CN1 and KPNIH31 lost
attR at the site of Tn4401a-blaKPC-2 (green bar) conjugating with the PsP3-like prophage (blue bar).
Additionally, CN1 and KPNIH31 had identical sequences in the region, and both contained an insertion
of group II intron (orange bar) in the prophage.
Huang et al. Antimicrobial Agents and Chemotherapy
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MS6671 (2014, United Arab Emirates), SKGH01 (2015, United Arab Emirates), and AATZP
(2014, United States) but without a 2-kb insertion of a retroelement containing a group
II intron reverse transcriptase (Fig. 3D). Notably, these chromosomes contained both
32-bp phage attachment sites (attL and attR) with a consensus sequence of TGGGTTT
GAACCAACGACCAAGCGATTATGAG. In contrast, with the Tn4401a-blaKPC-2 transposon
integrated into the chromosomes of CN1 and KPNIH31, one phage attachment site
(attR) was eliminated (Fig. 3D).
Association of CRISPR with chromosomal integration of multiple -lactamase
genes. About 360 kb downstream of the prophage site in CN1 chromosome
(1069045..1071450), we identiﬁed a CRISPR locus with a consensus direct repeat (DR),
CGGTTTATCCCCGCTGGCGCGGGGAACAC (29 bp in length), and 39 spacers. Proximate
to and upstream of the CRISPR sequences, there was a cluster of eight CRISPR-
associated cas genes (cas operon) (Fig. 4A). We then conducted a survey of the
CRISPR-cas system on 64 complete genomes of K. pneumoniae publicly available at the
NCBI genome database (as of May 2016, including our own three genomes). We
identiﬁed 22 (34%) strains harboring the CRISPR-cas array in the chromosome. All of the
CRISPR-cas arrays in K. pneumoniae strains belonged to type I-E in the classiﬁcation of
CRISPR-cas systems (19, 20). On the basis of their distinguishable features, we further
classiﬁed them into two distinctive subtypes, a and b (Table S4 and Fig. 4B). In subtype
a, two CRISPRs were separated by the cas operon; the DR sequences were either 28 or
29 bp in length and had consensus with 2 to 3 variables in the middle; also, the cas
operons were variable in cas genes and their order, occasionally with a transposase
gene integrated in the middle (Fig. 4B). In contrast, subtype b was quite consistent and
stable, containing the same DR (29 bp in length) and cas operon with only one CRISPR
downstream of the cas operon (Fig. 4B). In both subtypes a and b, the number and
sequence of spacers varied in each strain, which might represent its own established
immune system.
Eight of 22 (36.4%) K. pneumoniae isolates harboring the CRISPR-cas array carried
multiple -lactamase genes in their chromosomes. In contrast, multiple chromosomal
-lactamase genes were detected in only 3 of 42 (7.1%) K. pneumoniae strains without
CRISPR-cas in their chromosomes (P  0.0164) (Table S5).
There were ﬁve K. pneumoniae strains containing both the PsP3-like prophage site
and subtype b CRISPR-Cas array in the chromosome, i.e., CN1, KPNIH31, AATZP,
FIG 4 CRISPR-cas system in K. pneumoniae. (A) A zoomed-in view of CRISPR-cas array insertion in the CN1 chromosome, showing the
cas operon of eight cas genes followed by sequence repeats with spacers. (B) A schematic view of two subtypes (a and b) of the
CRISPR-cas system in K. pneumoniae. The consensus sequences were generated in WebLogo in analysis of direct repeats collected from
22 CRISPR arrays and grouped into two subtypes. Numbers and sizes of direct repeats, spacers, and cas genes are not to scale.
Chromosomal blaKPC and blaCTX-M in K. pneumoniae Antimicrobial Agents and Chemotherapy
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MS6671, and SKGH01. Intriguingly, four of them carried multiple -lactamase genes in
the chromosome. Instead of multiple copies of blaCTX-M-15 observed in CN1 and
KPNIH31, three copies of blaOXA-181 (a carbapenem-hydrolyzing oxacillinase) were
carried by MS6671 and SKHG01, in addition to one blaCTX-M-15 copy and one blaSHV-11
copy, in the chromosome (Table S4). Strain AATZP was exceptional, carrying only one
chromosomal blaSHV-11 copy but blaOXA-9 and blaTEM-1A in one plasmid (pKPN-041) and
blaCTX-M-15, blaOXA-1, and blaNDM-1 in another (pNDM-1fa) (21). Upon investigating
spacer sequences in these ﬁve K. pneumoniae strains, we found that they shared
identical spacers, except that four “old” spacers in the 3= extremities of CRISPR arrays
were eliminated from CN1 and KPNIH31 (Table S6). Sequence homology search further
demonstrated that four spacers (1, 28, 29, and 38 in CN1) targeted a variety of K.
pneumoniae plasmids, of which the “newest” one (1; GAGCAGGCACCCGCCGCAACGAC
GAAGAGCGC) at the 5= extremities of CRISPR arrays targeted more than 200 plasmids.
Some of these plasmids were hit more than one time, and most of them carried
antimicrobial resistance genes, including blaKPC-2 (e.g., p628-KPC) and blaCTX-M-15 (e.g.,
pKpN01-CTX). Notably, of 43 spacers in AATZP, none were homologous to any se-
quence of its plasmid pKPN-1fa carrying blaCTX-M-15.
DISCUSSION
To date, the ESBL and KPC -lactamase genes blaCTX-M and blaKPC have been
reported to be carried on separate plasmids in most Enterobacteriaceae strains (13–16),
just as we observed in clinical K. pneumoniae isolates CR14 and NY9 in this study. Since
plasmids can be horizontally transferred across strains, species, and even genera,
plasmid-borne antimicrobial resistance is of concern. Moreover, we report here a
clinical K. pneumoniae isolate, CN1, with multiple copies of blaCTX-M-15 and blaKPC-2
integrated in the chromosome. Our whole-genome sequence analysis suggests that
these chromosomal blaCTX-M-15 and blaKPC-2 elements mobilized from plasmids. Such
integration and dissemination of antimicrobial resistance genes illustrates the currently
complex pandemic scenario of MDR K. pneumoniae isolates.
It is uncommon for K. pneumoniae to harbor multiple -lactamase genes in its
chromosome, especially multiple copies of the same -lactamase gene. Most recently,
it has been reported that strain KPNIH31 carries two chromosomal blaCTX-M-15 copies
with ISEcp1 (although one is disrupted by IS903, as shown in Fig. 2C) (15), KPNIH33
carries two chromosomal blaKPC-3 copies with Tn4401b (14, 15), and MS6671 carries
three chromosomal blaOXA-181 copies with ISEcp1 (Fig. 1B) (22). We describe that the
CN1 chromosome carries three blaCTX-M-15 copies with ISEcp1 and one blaKPC-2 copy
with Tn4401a. Most interestingly, our comparative genomic analysis demonstrates that
strains KPNIH31, MS6671, and CN1 share the same chromosomal architecture feature:
multiple copies of a -lactamase gene linked with ISEcp1, a large PsP3-like prophage
sequence, and a CRISPR-cas array with the same DR sequence. The CRISPR-cas system
is a prokaryotic immune system that confers resistance to foreign genetic elements,
such as those present within plasmids and phages, and provides a form of acquired
immunity in its spacers (19, 20). Coexistence of a CRISPR-cas array and multiple copies
of the same -lactamase genes in the chromosome lead us to hypothesize a mecha-
nism for antimicrobial resistance genes jumping from plasmids to the chromosome,
along with their associated mobile genetic elements. We postulate that the novel
acquired spacer in the CRISPR-cas array could induce degradation of its targeting
plasmids in the host or in an environmental niche and promote antimicrobial resistance
gene mobilization from plasmids into the chromosome when the bacteria are under
the selective force of antimicrobial agents. Notably, isolate CN1 has relatively fewer
plasmids than isolates CR14 and NY9.
Recently, the CRISPR-cas system has been proposed and tested for application
against antimicrobial resistance using bacteriophage as a vector (23–25). However, our
whole-genome analysis reveals that both CRISPR-cas array and bacteriophage could be
integrated into the chromosome, as well as the antimicrobial resistance genes along
with their mobile genetic elements. This suggests that CRISPR targeting on the plas-
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mids carrying antimicrobial resistance leads to resistance genes being mobilized into
the chromosome. Efﬁcient CRISPR targeting should be on sequences speciﬁc to the
antimicrobial resistance gene itself. It also suggests that vector sequences, such as
bacteriophages or plasmids, invade the chromosome. Thus, the genetic components of
the vector should be carefully considered to avoid long-term genetic contamination
when designing the CRISPR-cas strategies against antimicrobial resistance. Additionally,
the existing CRISPR-cas array in some bacteria should be taken into account and utilized
wisely.
In conclusion, this study describes three complete genomes of MDR K. pneumoniae
carrying both blaCTX-M and blaKPC. Consistent with previous observations, transpositions
of blaCTX-M-15 and blaKPC-2 in chromosomes or plasmids are linked to the mobile
genetic elements ISEcp1 and Tn4401a, respectively. Such mobile elements provide
opportunities for horizontal gene transfer of antibiotic resistance genes among
plasmids and between plasmid and chromosome, posing complications for the
efﬁcient prevention and control of MDR bacterial infections in health care. Our
comparative genomic analysis further reveals that genomic characteristics of
CRISPR-cas arrays, ISEcp1-blaCTX-M-15 and Tn4401a-blaKPC-2 mobile elements, and
prophage sites in K. pneumoniae strains allow differentiation and tracking of the
prevalent MDR K. pneumoniae strains and give us insights into the molecular
mechanisms of bacterial evolution and adaptation.
MATERIALS AND METHODS
Clinical isolates. Three K. pneumoniae isolates carrying both blaCTX-M and blaKPC (CR14, NY9, and
CN1) were included in this study. These three isolates were identiﬁed from 394 nonduplicate K.
pneumoniae clinical isolates from the WMC (2005 to 2014; n  374) and two New York City hospitals
(2013; n  20) that were analyzed by next-generation sequencing. The clinical isolates from two
academic hospitals in metropolitan New York City, Bellevue Hospital (n 11) and New York-Presbyterian
Hospital (n  9), were included for purposes of comparison. All K. pneumoniae isolates were recovered
from patient specimens and identiﬁed by standard microbiology procedures at the clinical microbiology
laboratories of the three hospitals. The WMC is a 643-bed academic tertiary-care medical center in
Westchester County, New York. The Institutional Review Board of New York Medical College approved
this study.
Antimicrobial susceptibility testing. Antimicrobial susceptibility testing was performed for all
antimicrobial agents, other than those listed below, with the MicroScan Walk-Away 96 system (Beckman
Coulter) (17). Etests (bioMérieux) were employed for susceptibility assessment of cefotaxime, ceftazidime,
imipenem, meropenem, tigecycline, and colistin, and results were interpreted according to the Clinical
and Laboratory Standards Institute (CLSI) guidelines (26).
Whole-genome sequencing. Genomic DNA was extracted from each isolate using a QIAamp DNA
kit (Qiagen) and subjected to both short- and long-read massively parallel sequencing. Short-read
sequencing was performed in the MiSeq system using the Nextera XT sample preparation kit (Illumina),
reaching an averaged depth of more than 250 in coverage for each isolate. Long-read sequencing was
performed using the Paciﬁc Biosciences (PacBio) RSII single-molecule real-time (SMRT) sequencing
system after processing the SMRTbell library using g-TUBE fragmentation (Covaris), the BluePippin size
selection system for DNA fragments of 7 to 50 kb (Sage Science), and the SMRTbell template preparation
kit (PacBio), reaching an averaged depth of more than 50 in coverage.
Whole-genome de novo assembly. Sequence assembly was conducted de novo on Illumina short
reads using Velvet v.1.2.10 (27) and on the PacBio long reads using the Hierarchical Genome Assembly
Process 3, version 2.3.0, pipeline (HGAP3) and Quiver tools in SMRT Analysis v.2.3.0 (PacBio) (28).
Sequence assembly was also conducted with the SPAdes Genome Assembler (v3.5.0) for the combination
of both Illumina short reads and PacBio long reads (29). Both BWA (30) and Bowtie2 (31) algorithms were
employed for short reads aligned to the draft of the whole-genome assembly, whereas BLASR (32) was
employed for long-read alignment. The ﬁnal whole-genome sequences were reviewed under the
Integrative Genomics Viewer (33, 34), manually modiﬁed, and trimmed into circular chromosome and
plasmids.
Whole-genome analysis. The whole-genome sequences were annotated by the NCBI Prokaryotic
Genome Automatic Annotation Pipeline (35). Multilocus sequence typing of each isolate was analyzed
using SRST2 (36). Chromosome architecture comparisons between strains were carried out using Mauve
2.3.1 (37). Insertion sequences, CRISPR, and prophage sites were characterized by IslandViewer 3 (38),
CRISPRFinder (39), and PHASTER (40), respectively. Antibiotic resistance genes were scanned by Res-
Finder 2.1 (41). Plasmid incompatibility (Inc.) groups were assessed by BLASTn and by using the
PlasmidFinder database from the Center for Genomic Epidemiology (42). BLASTn was also used for other
sequence homolog searches.
Nucleotide sequence accession numbers. The complete genome sequences have been deposited
in GenBank under BioProject identiﬁer PRJNA319426 and accession numbers CP015382 to CP015397.
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